Substituted naphthyridines and their use as Syk kinase inhibitors

Details for Australian Patent Application No. 2011209274 (hide)

Owner Boehringer Ingelheim International GmbH

Inventors Hoffmann, Matthias; Dahmann, Georg; Fiegen, Dennis; Handschuh, Sandra; Klicic, Jasna; Linz, Guenter; Schaenzle, Gerhard; Schnapp, Andreas; East, Stephen P.; Mazanetz, Michael Philip; Scott, John; Walker, Edward

Agent Spruson & Ferguson

Pub. Number AU-A-2011209274

PCT Pub. Number WO2011/092128

Priority 10152159.9 29.01.10 EP

Filing date 21 January 2011

Wipo publication date 4 August 2011

International Classifications

C07D 471/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/4375

C07D 519/00 Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or

Event Publications

19 July 2012 PCT application entered the National Phase

  PCT publication WO2011/092128 Priority application(s): WO2011/092128

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011209276-Coating means comprising composite particles

2011209249-Apparatus for modified atmosphere packaging of products placed in trays